Amanda Bruegl

Oregon Health & Science University

Papers

2

Total Citations

6

H-Index

1

About

Dr. Amanda Bruegl is a gynecologic oncologist whose research centers on improving surgical outcomes for endometrial cancer, particularly in patients with obesity—a major risk factor for the disease. Her work addresses a critical gap in cancer care: the reliability of sentinel lymph node (SLN) mapping in individuals with very high body mass index (BMI). In her landmark 2023 study, she compared SLN mapping success rates in patients with BMI <45 versus those with BMI ≥45, finding that the procedure remains feasible and effective even in the highest BMI groups. This work, which has garnered 5 citations, challenges previous assumptions that morbid obesity compromises surgical accuracy. Her 2022 study further reinforced these findings, emphasizing that obesity increases surgical complexity but does not preclude successful mapping. Dr. Bruegl’s contributions are vital for tailoring cancer treatment to underserved populations, ensuring that patients with obesity receive the same standard of care as others. Her research has direct implications for reducing surgical morbidity and improving staging accuracy, making her a key voice in gynecologic oncology and surgical innovation.

Research Focus

Key Achievements

1
H-Index
2
Papers
6
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Success Rates of Sentinel Lymph Node Mapping for Endometrial Cancer in Patients with Body Mass Index &lt; 45 Compared with Body Mass Index ≥ 45
5 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Oregon Health & Science University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago